Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
{{output}}
Respiratory disease caused by coronavirus infection remains a global health crisis. Although several SARS-CoV-2-specific vaccines and direct-acting antivirals are available, their efficacy on emerging coronaviruses in the future, including SARS-CoV-2 variants,... ...
